Labor. Farmac. R Br
ROVI
EUR
STOCK MARKET:
STN
Closed
 
...
Large gap with delayed quotes
Official
08/29/2025 - 17:35:29
Bid
08/29/2025 - 18:00:44
Bid
Volume
Ask
08/29/2025 - 18:00:44
Ask
Volume
58.00
-0.35 ( -0.60% )
57.15
72
58.80
100
More information
Analysis by TheScreener
29.08.2025
Evaluation Neutral  
Interest Strong  
Sensibility High  
Analysis date: 29.08.2025
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 15.08.2025.
Interest
  Strong
Three stars since 29.08.2025.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 29.08.2025 at a price of 58.00.
Evaluation
  Strongly undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 09.05.2025.
4wk Rel Perf
  4.12%
 
The four-week dividend-adjusted overperformance versus STOXX600 is 4.12%.
Sensibility
  High
The stock has been on the high-sensitivity level since 07.02.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.26%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.95%.
Mkt Cap in $bn
  3.42
With a market capitalization between $2 & $8bn, LABORATORIOS FARMA is considered a mid-cap stock.
G/PE Ratio
  1.58
A "Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings" ratio higher than 1.5 indicates that the stock's price presents a discount to growth >40% in this case.
LT P/E
  13.81
The estimated PE is for the year 2027.
LT Growth
  20.05%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  9
Over the last seven weeks, an average of 9 analysts provided earnings per share estimates.
Dividend Yield
  1.80%
The twelve month estimated dividend yield represents 24.81% of earnings forecasts.
Beta
  52
For 1% of index variation, the stock varies on average by 0.52%.
Correlation
  0.24
Stock movements are strongly independent of index variations.
Value at Risk
  13.93
The value at risk is estimated at EUR 13.93. The risk is therefore 24.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  22.07.2011